Discover how oral small molecule GLP‑1 receptor agonists could replace weekly injections like semaglutide and tirzepatide, offering scalable, room‑temperature‑stable pills that transform obesity and type 2 diabetes care worldwide.
Explore how AI is transforming protein and peptide drug discovery—from GLP‑1 multi-agonist “smart” peptides for metabolic disease to de novo mini-protein binders. Learn why complex biologics are ideal for deep learning, generative models, and in silico optimization.